Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Complete response of a stage IV mucinous cystadenocarcinoma of the ovary to systemic chemotherapy employing paclitaxel and carboplatin
Autore:
Yokoyama, Y; Kaji, H; Kondoh, H; Takeuchi, E; Yamasaki, Y; Inui, Y;
Indirizzi:
Kochi Red Cross Hosp, Dept Pathol, Kochi, Japan Kochi Red Cross Hosp Kochi Japan Cross Hosp, Dept Pathol, Kochi, Japan Kochi Red Cross Hosp, Dept Internal Med, Kochi, Japan Kochi Red Cross Hosp Kochi Japan Hosp, Dept Internal Med, Kochi, Japan Kochi Red Cross Hosp, Dept Obstet & Gynecol, Kochi, Japan Kochi Red Cross Hosp Kochi Japan p, Dept Obstet & Gynecol, Kochi, Japan
Titolo Testata:
GYNECOLOGIC AND OBSTETRIC INVESTIGATION
fascicolo: 3, volume: 52, anno: 2001,
pagine: 210 - 214
SICI:
0378-7346(2001)52:3<210:CROASI>2.0.ZU;2-K
Fonte:
ISI
Lingua:
ENG
Soggetto:
TERM FOLLOW-UP; GYNECOLOGIC-ONCOLOGY-GROUP; 2ND-LOOK LAPAROTOMY; PHASE-I; CANCER; CARCINOMA; CISPLATIN; 2ND;
Keywords:
ovarian cancer, advanced; cystadenocarcinoma, mucinous; chemotherapy; paclitaxel; carboplatin;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Life Sciences
Citazioni:
18
Recensione:
Indirizzi per estratti:
Indirizzo: Yokoyama, Y Shikoku Cent Hosp, Dept Obstet & Gynecol, Kawanoe Cho 2233, Kawanoe City, Ehime 7990193, Japan Shikoku Cent Hosp Kawanoe Cho 2233 KawanoeCity Ehime Japan 7990193
Citazione:
Y. Yokoyama et al., "Complete response of a stage IV mucinous cystadenocarcinoma of the ovary to systemic chemotherapy employing paclitaxel and carboplatin", GYNECOL OBS, 52(3), 2001, pp. 210-214

Abstract

Background. The survival rate of patients with advanced-stage mucinous cystadenocarcinoma of the ovary is dismal and no best treatment is known. We report a case of complete response of a stage IV mucinous cystadenocarcinomaof the ovary to systemic chemotherapy employing paclitaxel and carboplatin. Case: A 51-year-old nullipara diagnosed with International Federation of Gynecology and Obstetrics stage IV mucinous cystadenocarcinoma of the ovaryunderwent cytoreductive surgery followed by systemic chemotherapy employing paclitaxel and carboplatin every 4 weeks for 3 courses. The patient tolerated chemotherapy well, demonstrated a remarkable response showing no evidence of malignancy at a second-look laparotomy. As a consolidation chemotherapy after negative second-look laparotomy, she underwent another three courses of chemotherapy of the same regimen, and is showing no evidence of disease. Conclusion: Paclitaxel and carboplatin may be effective in treating mucinous cystadenocarcinoma of the ovary. Copyright (C) 2001 S. Karger AG, Basel.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 19/09/20 alle ore 20:57:24